RecruitingNot ApplicableNCT04545957

Jump: MR Simulation For Radiation Therapy Master Protocol

Judging MR Simulation Procedures: A Phase I-II Study of the Use of Magnetic Resonance Imaging Simulation in the Planning of Radiation Treatments


Sponsor

Brigham and Women's Hospital

Enrollment

86 participants

Start Date

Oct 14, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a broad platform study that uses MRI-guided simulation to improve the planning of radiation therapy for patients with various cancers. Individual sub-studies focus on specific cancer types and are listed separately. **You may be eligible if...** - You are 18 or older with a confirmed malignancy that requires radiation therapy - Your general health is reasonable (ECOG score 0–2) - You are able to understand and sign a consent form - You meet the specific disease criteria for one of the sub-protocols **You may NOT be eligible if...** - You have had a serious allergic reaction to gadolinium-based contrast dye (if contrast MRI is required) - You are unable to undergo an MRI scan - You do not meet the specific eligibility requirements for any available sub-study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMRI Simulator

Radiation mapping to define the target for radiation.acquiring MR data at the specified timepoint in a patient's care plan and ability to identify the radiation target and develop a radiation therapy plan on the MR data.

RADIATIONRadiation Therapy

In Phase I, radiation will be institutional standard per disease site. In Phase II, either radiation according to MR-based dose painting or adjusted RT. These adjusted doses and/or RT will vary per disease site and will be pre-specified in the subprotocols.


Locations(2)

Brigham and Women Hospital

Boston, Massachusetts, United States

Dana Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04545957


Related Trials